ILMN Logo

Illumina, Inc. (ILMN) 

NASDAQ
Market Cap
$24.15B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
109 of 776
Rank in Industry
5 of 42

Largest Insider Buys in Sector

ILMN Stock Price History Chart

ILMN Stock Performance

About Illumina, Inc.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as …

Insider Activity of Illumina, Inc.

Over the last 12 months, insiders at Illumina, Inc. have bought $991,672 and sold $35,545 worth of Illumina, Inc. stock.

On average, over the past 5 years, insiders at Illumina, Inc. have bought $991,672 and sold $18.23M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Thaysen Jacob (Chief Executive Officer) — $1.98M.

The last purchase of 7,330 shares for transaction amount of $991,672 was made by Thaysen Jacob (Chief Executive Officer) on 2024‑02‑22.

List of Insider Buy and Sell Transactions, Illumina, Inc.

2024-02-22PurchaseChief Executive Officer
7,330
0.0046%
$135.29$991,672-5.77%
2023-11-07SaleSVP, Chief People Officer
315
0.0002%
$112.84$35,545+13.22%
2023-08-22SaleSVP, Chief Commercial Officer
500
0.0003%
$167.04$83,520-20.83%
2023-07-24SaleSVP, Chief Commercial Officer
500
0.0003%
$190.08$95,040-29.75%
2023-06-22SaleSVP, Chief Commercial Officer
500
0.0003%
$200.00$100,000-33.81%
2023-05-22SaleSVP, Chief Commercial Officer
5,000
0.0032%
$208.59$1.04M-34.05%
2023-03-01SaleSVP, Chief People Officer
3,917
0.0025%
$199.06$779,737-19.52%
2023-02-22SaleSVP, Chief Technology Officer
5,398
0.0034%
$201.74$1.09M-17.67%
2023-02-06SaleSVP, Chief Commercial Officer
500
0.0003%
$211.57$105,785-12.16%
2023-01-09SaleSVP, Chief People Officer
871
0.0005%
$205.57$179,051-9.26%
2023-01-06SaleSVP, Chief Commercial Officer
500
0.0003%
$204.58$102,290-6.35%
2022-12-06SaleSVP, Chief Commercial Officer
500
0.0003%
$212.63$106,315-5.57%
2022-11-08SaleSVP, Chief Technology Officer
361
0.0002%
$218.00$78,698-8.48%
2022-11-07SaleSVP, Chief Commercial Officer
500
0.0003%
$223.65$111,825-8.07%
2022-11-07SaleSVP, Chief People Officer
1,045
0.0007%
$223.65$233,714-8.07%
2022-10-06SaleSVP, Chief Commercial Officer
500
0.0003%
$216.59$108,295-4.75%
2022-07-05SaleSVP, Chief Technology Officer
539
0.0004%
$200.00$107,800+7.40%
2022-06-10SaleSVP, Chief Commercial Officer
250
0.0002%
$214.85$53,713+1.44%
2022-04-28SaleSVP & General Counsel
368
0.0002%
$300.13$110,448-30.39%
2022-04-12SaleSVP, Chief People Officer
100
<0.0001%
$355.38$35,538-38.64%

Insider Historical Profitability

<0.0001%
Thaysen JacobChief Executive Officer
14861
0.0093%
$151.6110
MOELLER GERALDdirector
17544
0.011%
$151.6115+43.15%
BOWMAN A BLAINEdirector
16868
0.0106%
$151.611136<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$2.51B11.4518.25M+0.37%+$9.14M0.05
BlackRock$1.9B8.6713.81M+3.82%+$69.77M0.04
State Street$935.46M4.286.81M+1.32%+$12.18M0.04
Edgewood Management$913.97M4.186.66M-3.24%-$30.59M2.46
Baillie Gifford Co$787.72M3.65.74M+8.73%+$63.26M0.61
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.